The American SECURITIES AND EXCHAGEN (SEC) commission delayed various funds for the Stock Exchange (ETF) based on Altcoin on March 11. According to Bloomberg Etf James Seyffart analyst, the approval ratings for these ETFs this year are still relatively high.
The decisions on Graycale’s deposits for Dogecoin (DOGE), XRP, Litecoin (LTC) and Cardano (ADA) ETF were delayed. The SEC also delayed decisions for ETF XRP filed by Canary Capital, Bitwise and 21Shares.
The regulator also postponed decisions on ETF Solana (soil) filed by 21Shares, Canary and Vaneck. Canary’s Litecoin deposit was the last delay of the FNB linked to Altcoin.
Other Crypto ETF delays include creation in kind and buyouts for the Ibit of Blackrock, as well as FBTC and Feth de Fidelity. 21Shares has also seen a delay in the proposal to include the milestone in Son Etf Etf (ETH).
Despite delays, the SEC recognized the Graycale deposit for an ETF Hedera (Hbar) and the deposit linked to Bitwise Doge.
In addition, on March 11, Franklin Templeton filed an S-1 form for an ETF XRP, joining a new product race negotiated in exchange for Altcoin.
High chances of approval
Seyffart evaluated that the multiple delays were expected, because “it is a standard procedure”. He added that Paul Atkins was not confirmed as the new president of the SEC, who is also a factor in delays.
The analyst also pointed out that the end deadlines for a SEC decision on all FNBs are due in October and that the chances of approval are still relatively high.
In February, analyst Eric Balchunas from Seyffart and Bloomberg ETF Senior Etf Eric Balchunas published their approval ratings For ETF Litecoin, Solana, XRP and Dogecoin.
The LTC leads the dimensions with a probability of approval of 90% this year, Doge holding the second percentage in larger 75%. Sol closes with 70% chance and XRP with 65% chance of approval.
Analysts stressed that these chances were less than 5% before President Donald Trump’s November elections, making the new figures relatively high.
In addition, the chances for all ETFs listed by Balchunas and Seyffart could increase if regulatory conditions in the United States improve even more.
